The S&P/ASX 200 Index (ASX: XJO) lifted higher this Wednesday, gaining a solid 0.71% to finish at a flat 7,999 points.
The S&P/ASX 200 Index (ASX: XJO) is riding higher following the latest inflation figures. Here’s what you need to know.
This ASX 200 share could be a top buy for investors right now according to analysts at Ord Minnett. Here's why it is ...
There are a number of high-quality S&P/ASX 200 Index (ASX: XJO) stocks that investors can choose. A leading fund manager has ...
Nvidia's stock no longer trades at a huge premium. It's now priced at 26 times forward earnings, which is cheaper than many ...
This high-yielding S&P/ASX 200 Index (ASX: XJO) dividend stock has soared 19% in a month. Here’s why it could keep leaping ...
Goldman Sachs has a buy rating and $11.80 price target on the company's shares. Another ASX dividend stock that Goldman Sachs ...
S&P/ASX 200 Index (ASX: XJO) copper stocks could indirectly benefit from Donald Trump’s threatened 25% tariffs. Here’s how.
Pro Medicus shares have soared over the last two years to record high's. But after a 20% sell off, is it time for new ...
Commonwealth Bank of Australia (ASX: CBA) shares have delivered investors success. Is this particular reason why the bank has ...
While Cognitive Market Research expects the global metal detector market to grow at a compound annual growth rate (CAGR) of 6 ...
Top brokers have named Pro Medicus Limited (ASX: PME) and these ASX shares as buys. Here's why they are bullish on them.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results